SCHEMBL31509825

SCHEMBL31509825

CNc1ncccc1CN(CC(=O)OC(C)(C)C)C(=O)OCOP(=O)(OC(C)(C)C)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25244630 1.00 — —
SCHEMBL25683911 0.93 — —
SCHEMBL31509777 0.86 NAMPT (0.31) —
SCHEMBL31509893 0.85 SSTR4 (0.31) —
SCHEMBL31509917 0.85 TRPV1 (0.32) —
SCHEMBL30392867 0.84 HTT (0.32) —
SCHEMBL25213440 0.84 HTT (0.32) —
SCHEMBL31509851 0.83 — —
SCHEMBL31509752 0.83 — —
SCHEMBL31509730 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250127801-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-24 — — US disclosed
WO-2025080850-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-04-17 — — WO disclosed
Send feedback